These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8370148)

  • 1. Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling.
    Kotze MJ; Davis HJ; Bissbort S; Langenhoven E; Brusnicky J; Oosthuizen CJ
    Clin Genet; 1993 Jun; 43(6):295-9. PubMed ID: 8370148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.
    Rubinsztein DC; Raal FJ; Seftel HC; Pilcher G; Coetzee GA; van der Westhuyzen DR
    Arterioscler Thromb; 1993 Jul; 13(7):1076-81. PubMed ID: 8318509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.
    Steyn K; Goldberg YP; Kotze MJ; Steyn M; Swanepoel AS; Fourie JM; Coetzee GA; Van der Westhuyzen DR
    Hum Genet; 1996 Oct; 98(4):479-84. PubMed ID: 8792826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
    Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
    Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
    Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations.
    Kotze MJ; De Villiers WJ; Steyn K; Kriek JA; Marais AD; Langenhoven E; Herbert JS; Graadt Van Roggen JF; Van der Westhuyzen DR; Coetzee GA
    Arterioscler Thromb; 1993 Oct; 13(10):1460-8. PubMed ID: 8399083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia.
    Graadt van Roggen JF; van der Westhuyzen DR; Coetzee GA; Marais AD; Steyn K; Langenhoven E; Kotze MJ
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):765-72. PubMed ID: 7773731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
    Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
    Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
    Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
    Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family.
    Takada D; Ezura Y; Ono S; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN; Emi M
    J Atheroscler Thromb; 2003; 10(2):79-84. PubMed ID: 12740481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.